McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for MCK
142.13
-0.57 (-0.40%)
Nov 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 140.89 - 142.84
52 week 133.82 - 169.29
Open 141.71
Vol / Avg. 1.85M/2.40M
Mkt cap 29.63B
P/E 6.73
Div/yield 0.34/0.96
EPS 21.11
Shares 208.00M
Beta 1.21
Inst. own 92%
Feb 7, 2018
Q3 2018 McKesson Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 7, 2017
McKesson Corp at Credit Suisse Healthcare Conference - Webcast
Oct 26, 2017
Q2 2018 McKesson Corp Earnings Release
Oct 26, 2017
Q2 2018 McKesson Corp Earnings Call - Webcast
Sep 12, 2017
McKesson Corp at Morgan Stanley Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2017
Net profit margin 0.11% 2.66%
Operating margin 0.46% 3.58%
EBITD margin - 2.13%
Return on average assets 0.36% 8.98%
Return on average equity 0.04% 51.89%
Employees 78,000 -
CDP Score - D

Address

1 Post St
SAN FRANCISCO, CA 94104-5203
United States - Map
+1-415-9838300 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 56
Bio & Compensation  - Reuters
Kathleen D. McElligott Executive Vice President, Chief Technology Officer, Chief Information Officer
Age: 61
Bio & Compensation  - Reuters
Lori Ann Schechter Executive Vice President, Chief Compliance Officer, General Counsel
Age: 55
Bio & Compensation  - Reuters
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 56
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 61
Bio & Compensation  - Reuters
Bansi Nagji Executive Vice President - Corporate Strategy and Business Development
Age: 52
Bio & Compensation  - Reuters
Edward A. Mueller Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 67
Bio & Compensation  - Reuters
N. Anthony Coles Jr., M.D. Independent Director
Age: 57
Bio & Compensation  - Reuters